Signaling Pathways - Neurocognitive Disorders - Immunosuppressive Therapy - Lung Carcinoma - Colon Carcinoma
清除全部
- B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂
- B2173 CP-673451Target: PDGFRSummary: PDGFRα/β抑制剂
- A1196 SGX-5231 CitationTarget: METSummary: 高度选择性的、ATP竞争性的Met抑制剂
- A1877 XAV-9391 CitationTarget: TNKSSummary: Tankyrase 1/2抑制剂
- A1821 Ki8751Target: VEGFRSummary: VEGFR-2有效的、选择性抑制剂
- A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂
- A3712 PF-04217903 methanesulfonateTarget: c-METSummary: c-Met抑制剂
- A3209 AXL1717中文名: 鬼臼毒素Target: Insulin-like growth factor receptors(IGFRs)Summary: IGF-1R抑制剂,口服有效。
- A3191 Ascomycin(FK 520)中文名: 长川霉素Target: phosphatasesSummary: FK-520 类似物,大环内酯类免疫抑制剂
- A4383 Tolcapone中文名: 托卡朋Target: Catechol O-Methyltransferase (COMT)Summary: COMT抑制剂